Physician profile
Krishnan Venkatesan
NPI 1245431998
$3,631.75
in general payments reported to CMS, 2019-2025
19 companies · $262 in 2025
The $262 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $18.18 · 2021: $225 · 2022: $1,777 · 2023: $626 · 2024: $435 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,322.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,790.70 | 2019-2025 | Ams 700 |
| Coloplast Corp | $141.88 | 2023-2024 | Titan |
| Abbvie INC. | $133.27 | 2023-2025 | Botox |
| Endo Pharmaceuticals INC. | $115.95 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $72.90 | 2023-2024 | Orgovyx |
| Antares Pharma, INC. | $50.52 | 2022-2025 | Xyosted |
| Merck Sharp & Dohme LLC | $47.37 | 2024-2025 | Keytruda |
| Progenics Pharmaceuticals, INC. | $35.65 | 2023 | Pylarify |
| Novartis Pharmaceuticals Corporation | $32.08 | 2025 | |
| Tolmar, INC. | $29.82 | 2023 | |
| Olympus America INC. | $27.25 | 2023 | Itind System |
| Immunitybio, INC. | $24.55 | 2025 | |
| Allergan, INC. | $21.00 | 2019 | |
| Teleflex LLC | $19.60 | 2019 | |
| Rigicon,INC. | $19.46 | 2023 | Rigi10 Malleable Penile Prosthesis |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $19.01 | 2019 | |
| Davol INC. | $18.18 | 2020 | |
| Myovant Sciences INC. | $18.18 | 2022 | |
| Cook Medical LLC | $14.38 | 2024 | Cook |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishnan Venkatesan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.